John Connell

Chief Scientific Officer at MAC Clinical Research, UK

Dr Connell has over 30 years’ experience in Early Phase Clinical Research. The majority of research has been focused on the application of specialist scientific techniques, including healthy volunteer pharmacodynamic models, that can be used to accelerate the drug development process. Dr Connell worked as Global Vice President of Pharmacodynamics for ICON Development Solutions before joining MAC Clinical Research in 2014 as Chief Scientific Officer. He has contributed to over 400 studies covering a wide range of therapeutic indications. At MAC he works closely with scientific teams at their MHRA accredited Early Phase Unit in Manchester and their state-of-the-art Sleep Facility in Liverpool.